NeoGenomics NEO Increase (Decrease) in Accounts Payable and Other Operating Liabilities
Increase (Decrease) in Accounts Payable and Other Operating Liabilities at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities.
The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about NeoGenomics's increase (decrease) in accounts payable and other operating liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NeoGenomics's increase (decrease) in accounts payable and other operating liabilities?
- NeoGenomics (NEO) reported increase (decrease) in accounts payable and other operating liabilities of $718K in Q1 2026.
- How has NeoGenomics's increase (decrease) in accounts payable and other operating liabilities changed year-over-year?
- NeoGenomics's increase (decrease) in accounts payable and other operating liabilities decreased by 37.2% year-over-year, from $1.14M to $718K.
- What is the long-term trend for NeoGenomics's increase (decrease) in accounts payable and other operating liabilities?
- Over 3 years (2022 to 2025), NeoGenomics's increase (decrease) in accounts payable and other operating liabilities has grown at a 69.8% compound annual growth rate (CAGR), from $958K to -$4.69M.